Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4863367
Max Phase: Preclinical
Molecular Formula: C80H114N8O8
Molecular Weight: 1315.84
Molecule Type: Unknown
Associated Items:
ID: ALA4863367
Max Phase: Preclinical
Molecular Formula: C80H114N8O8
Molecular Weight: 1315.84
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(CCCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43)NCCCCCCCCCCC(=O)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43
Standard InChI: InChI=1S/C80H114N8O8/c89-69(81-41-27-21-15-9-7-13-19-25-31-71(91)83-57-33-35-63-61(47-57)79-39-43-85-53-55-37-45-95-65-51-73(93)87(63)77(79)75(65)59(55)49-67(79)85)29-23-17-11-5-3-1-2-4-6-12-18-24-30-70(90)82-42-28-22-16-10-8-14-20-26-32-72(92)84-58-34-36-64-62(48-58)80-40-44-86-54-56-38-46-96-66-52-74(94)88(64)78(80)76(66)60(56)50-68(80)86/h33-38,47-48,59-60,65-68,75-78H,1-32,39-46,49-54H2,(H,81,89)(H,82,90)(H,83,91)(H,84,92)/t59-,60-,65-,66-,67-,68-,75-,76-,77-,78-,79+,80+/m0/s1
Standard InChI Key: SNCRHEFSSRKCHT-VQVSISRWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1315.84 | Molecular Weight (Monoisotopic): 1314.8760 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zlotos DP, Abdelmalek CM, Botros LS, Banoub MM, Mandour YM, Breitinger U, El Nady A, Breitinger HG, Sotriffer C, Villmann C, Jensen AA, Holzgrabe U.. (2021) C-2-Linked Dimeric Strychnine Analogues as Bivalent Ligands Targeting Glycine Receptors., 84 (2.0): [PMID:33596384] [10.1021/acs.jnatprod.0c01030] |
Source(1):